Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

NCT01240759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: S-707106 Dose A
DRUG: S-707106 Dose B
DRUG: S-707106 Dose C
DRUG: Placebo A tablet
DRUG: Metformin

Sponsor

Shionogi